| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $22.0M | -2.4% | +61.1% |
| SG&A Expense | $5.4M | +3.1% | +184.3% |
| Operating Income | -$27.4M | +1.4% | -76.2% |
| Income Tax | $0 | — | — |
| Net Income | -$25.2M | +21.7% | -49.3% |
| EPS (Basic) | -$0.48 | +44.2% | +91.0% |
| EPS (Diluted) | -$0.48 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $50.1M | -77.3% | +61.0% |
| Short-term Investments | $148.8M | — | +158.3% |
| Current Assets | $201.4M | -9.7% | +122.2% |
| Total Assets | $202.4M | -9.6% | +122.6% |
| Current Liabilities | $22.4M | +3.4% | +116.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$61.0M | — | -797.4% |
| Capital Expenditures | $193K | — | — |
| Investing Cash Flow | -$148.8M | — | — |
| Financing Cash Flow | $190.6M | — | +101.1% |
| Free Cash Flow | -$61.2M | — | — |
| +91.0% |
| $23.1M |
| +3.1% |
| +120.8% |
| Stockholders' Equity | $179.3M | -11.0% | +122.8% |